BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 15919901)

  • 21. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
    Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
    Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
    J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
    Yang Z; Wood C
    J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
    Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
    Yang Z; Yan Z; Wood C
    J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
    Carroll KD; Bu W; Palmeri D; Spadavecchia S; Lynch SJ; Marras SA; Tyagi S; Lukac DM
    J Virol; 2006 Oct; 80(19):9697-709. PubMed ID: 16973574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
    Jeong J; Papin J; Dittmer D
    J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator.
    Izumiya Y; Izumiya C; Hsia D; Ellison TJ; Luciw PA; Kung HJ
    J Virol; 2009 May; 83(9):4435-46. PubMed ID: 19244329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.
    Zhang YJ; Wang KY; Stein DA; Patel D; Watkins R; Moulton HM; Iversen PL; Matson DO
    Antiviral Res; 2007 Jan; 73(1):12-23. PubMed ID: 16842866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.
    Kato-Noah T; Xu Y; Rossetto CC; Colletti K; Papousková I; Pari GS
    J Virol; 2007 Dec; 81(24):13519-32. PubMed ID: 17913803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
    Sun R; Liang D; Gao Y; Lan K
    J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.